510(k) Report

FDA product code · Anesthesiology

Mask, Oxygen

BYGClass I21 CFR 868.5580510(k) exempt55 decisions since 197622 recalls

FDA lists BYG as exempt from 510(k): a device of this type needs no clearance unless one of the limits in 21 CFR 868.9 applies, such as a new intended use or a different fundamental technology. 55 FDA decisions since 1976. 22 recalls name this code, 0 of them Class I. The most-cited predicate is K942907, named by 1 later device.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, anesthesiology panel

Twenty years of BYG at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · BYG

FDA has decided no BYG device since 2007.

Median 510(k) review, days · BYG

Too few BYG 510(k)s in any year since 2007 to give a median.

Recalls per year · BYG

1in 2025

2011: 192017: 12018: 12025: 1
2007high 19 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · BYG

23in 2025

2007: 172008: 162009: 142010: 132011: 162012: 192013: 202014: 512015: 632016: 222017: 82018: 392019: 292020: 62021: 122022: 182023: 42024: 92025: 23
2007high 63 (2015) · low 4 (2023)2025

MAUDE reports naming product code BYG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—017
20080—016
20090—014
20100—013
20110—1916
20120—019
20130—020
20140—051
20150—063
20160—022
20170—18
20180—139
20190—029
20200—06
20210—012
20220—018
20230—04
20240—09
20250—123
20260—0—
FIG. 1 — BYG by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in BYG? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report